T. Rowe Price Investment Management’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$16M Buy
2025
Q1
$8.24M Buy
2024
Q4
$11.6M Buy
2024
Q3
$14.7M Buy
2024
Q2
$19.2M Buy
2024
Q1
$21.6M Buy